Novartis has decided to consolidate the production of CAR-T cell therapy KYMRIAH at a single site in the US meaning the company has ended its commercial manufacturing agreement with Melbourne-based Cell Therapies. …
Novartis to consolidate production of CAR-T therapy in the US
June 26, 2022 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
How can you not be sceptical about a rigged one-sided process?
May 27, 2025 - - Latest News -
Roche advances the development of innovative antibiotic
May 27, 2025 - - Latest News -
Australian-led ENZAMET prostate cancer trial to be presented at ASCO 2025
May 27, 2025 - - Latest News -
Leadership transition for medical affairs professional association
May 26, 2025 - - Latest News -
NSW Government to improve access to ADHD diagnosis and treatment
May 26, 2025 - - Latest News -
Immutep’s efti combination meets primary endpoint in Phase 2 soft tissue sarcoma
May 26, 2025 - - Australian Biotech -
Pharmac proposes change to ensure care continuity for more cancer patients
May 26, 2025 - - Latest News